Mark Mainwaring

646 total citations
28 papers, 531 citations indexed

About

Mark Mainwaring is a scholar working on Cell Biology, Oncology and Molecular Biology. According to data from OpenAlex, Mark Mainwaring has authored 28 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cell Biology, 11 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Mark Mainwaring's work include Hemoglobin structure and function (12 papers), Erythrocyte Function and Pathophysiology (4 papers) and Cancer Treatment and Pharmacology (4 papers). Mark Mainwaring is often cited by papers focused on Hemoglobin structure and function (12 papers), Erythrocyte Function and Pathophysiology (4 papers) and Cancer Treatment and Pharmacology (4 papers). Mark Mainwaring collaborates with scholars based in United States, Japan and Austria. Mark Mainwaring's co-authors include S.N. Vinogradov, Oscar H. Kapp, Albert V. Crewe, G. Polidori, Christopher J. Chetsanga, Paul R. Standley, Serge N. Vinogradov, John D. Hainsworth, Eloise Harman and Dani S. Zander and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Mark Mainwaring

28 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Mainwaring United States	13	299	264	103	83	66	28	531
June Snow United States	9	127 0.4×	237 0.9×	74 0.7×	28 0.3×	54 0.8×	11	488
Willem‐Jan Pannekoek Netherlands	17	256 0.9×	588 2.2×	181 1.8×	21 0.3×	85 1.3×	27	988
M. Viau France	14	121 0.4×	268 1.0×	41 0.4×	23 0.3×	95 1.4×	23	632
Taro Okazaki Japan	15	121 0.4×	407 1.5×	216 2.1×	12 0.1×	67 1.0×	71	849
Niaobh O’Donoghue Ireland	14	68 0.2×	546 2.1×	60 0.6×	208 2.5×	46 0.7×	22	853
Nick Menhart United States	16	80 0.3×	460 1.7×	44 0.4×	37 0.4×	116 1.8×	34	657
Ikuko Hayashi Japan	19	520 1.7×	947 3.6×	61 0.6×	27 0.3×	15 0.2×	36	1.3k
German B. Villanueva United States	18	249 0.8×	307 1.2×	67 0.7×	22 0.3×	16 0.2×	40	869
Kohji Nagano Japan	12	76 0.3×	383 1.5×	59 0.6×	137 1.7×	13 0.2×	18	550
Natalia G. Denissova United States	10	90 0.3×	605 2.3×	246 2.4×	14 0.2×	24 0.4×	10	761

Countries citing papers authored by Mark Mainwaring

Since Specialization

Citations

This map shows the geographic impact of Mark Mainwaring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Mainwaring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Mainwaring more than expected).

Fields of papers citing papers by Mark Mainwaring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Mainwaring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Mainwaring. The network helps show where Mark Mainwaring may publish in the future.

Co-authorship network of co-authors of Mark Mainwaring

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Mainwaring. A scholar is included among the top collaborators of Mark Mainwaring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Mainwaring. Mark Mainwaring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yardley, Denise A., William H. Liggett, Mark Mainwaring, et al.. (2019). A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer. Clinical Breast Cancer. 20(2). 89–97. 6 indexed citations

Kennedy, Andrew S., Dianna Shipley, Max Shpak, et al.. (2019). Regorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers. Frontiers in Oncology. 9. 624–624. 7 indexed citations

Bendell, Johanna C., Mathew J. Joseph, Mark Mainwaring, et al.. (2017). A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer. Cancer Investigation. 35(6). 386–392. 6 indexed citations

Yardley, Denise A., Davey B. Daniel, Mark Mainwaring, et al.. (2010). A Phase II Trial of Oxaliplatin and Trastuzumab in the Treatment of HER2-Positive Metastatic Breast Cancer. Cancer Investigation. 28(8). 865–871. 4 indexed citations

Yardley, Denise A., Howard A. Burris, Tiffanie Markus, et al.. (2009). Phase II Trial of Docetaxal Plus Imatinib Mesylate in the Treatment of Patients With Metastatic Breast Cancer. Clinical Breast Cancer. 9(4). 237–242. 28 indexed citations

Peacock, N. W., David R. Spigel, Mark Mainwaring, et al.. (2007). Preliminary results of a multicenter phase II trial of vinflunine (with trastuzumab in HER2+ pts) as first-line treatment in metastatic breast cancer. Journal of Clinical Oncology. 25(18_suppl). 1043–1043. 12 indexed citations

Barton, John H., William H. Liggett, Mark Mainwaring, et al.. (2006). Phase II pilot trial of imatinib mesylate with weekly docetaxel in metastatic breast cancer. Journal of Clinical Oncology. 24(18_suppl). 10716–10716. 5 indexed citations

Hainsworth, John D., Mark Mainwaring, M. Thomas, et al.. (2003). Gefitinib in the Treatment of Advanced, Refractory Non–Small-Cell Lung Cancer: Results in 124 Patients. Clinical Lung Cancer. 4(6). 347–355. 11 indexed citations

Mainwaring, Mark, Lisa M. Rimsza, SF Chen, et al.. (2002). Treatment of Refractory Acute Leukemia with Timed Sequential Chemotherapy Using Topotecan Followed by Etoposide+Mitoxantrone (T-EM) and Correlation with Topoisomerase II Levels. Leukemia & lymphoma. 43(5). 989–999. 12 indexed citations

10.

Rimsza, Lisa M., et al.. (2002). AML, angiogenesis, and prognostic variables. Blood. 100(4). 1517–1518. 2 indexed citations

11.

Chen, SF, et al.. (2002). Topotecan-induced topoisomerase IIα expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment. Cancer Chemotherapy and Pharmacology. 49(5). 347–355. 15 indexed citations

12.

Mainwaring, Mark, et al.. (2000). Complete Remission of Pulmonary Spindle Cell Carcinoma After Treatment With Oral Germanium Sesquioxide. CHEST Journal. 117(2). 591–593. 33 indexed citations

13.

Polidori, G., Mark Mainwaring, & S.N. Vinogradov. (1988). The effect of alkaline earth cations and of ionic strength on the dissociation of earthworm hemoglobin at alkaline PH. Comparative Biochemistry and Physiology Part A Physiology. 89(4). 541–545. 12 indexed citations

14.

Lightbody, James J., Mark Mainwaring, James Young, et al.. (1988). Immunological relatedness of annelid extracellular hemoglobins and chlorocruorins. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 90(2). 301–305. 2 indexed citations

15.

Standley, Paul R., Mark Mainwaring, Toshio Gotoh, & S.N. Vinogradov. (1988). The calcium, copper and zinc content of some annelid extracellular haemoglobins. Biochemical Journal. 249(3). 915–916. 20 indexed citations

16.

Kapp, Oscar H., Mark Mainwaring, S.N. Vinogradov, & Albert V. Crewe. (1987). Scanning transmission electron microscopic examination of the hexagonal bilayer structures formed by the reassociation of three of the four subunits of the extracellular hemoglobin of Lumbricus terrestris.. Proceedings of the National Academy of Sciences. 84(21). 7532–7536. 21 indexed citations

17.

Vinogradov, S.N., et al.. (1986). Bracelet protein: a quaternary structure proposed for the giant extracellular hemoglobin of Lumbricus terrestris.. Proceedings of the National Academy of Sciences. 83(21). 8034–8038. 81 indexed citations

18.

Vinogradov, Serge N., Paul R. Standley, Mark Mainwaring, Oscar H. Kapp, & Albert V. Crewe. (1985). The molecular size of Myxicola infundibulum chlorocruorin and its subunits. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 828(1). 43–50. 22 indexed citations

19.

Kapp, Oscar H., G. Polidori, Mark Mainwaring, Albert V. Crewe, & S.N. Vinogradov. (1984). The reassociation of Lumbricus terrestris hemoglobin dissociated at alkaline pH.. Journal of Biological Chemistry. 259(1). 628–639. 62 indexed citations

20.

Chetsanga, Christopher J., et al.. (1982). Analysis and excision of ring-opened phosphoramide mustard-deoxyguanine adducts in DNA.. PubMed. 42(7). 2616–21. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact